Terug
Dagbereik
€ 22,34
€ 22,98
52-Weeksbereik
€ 15,47
€ 27,22
Volume
232.221
50D / 200D Gem.
€ 22,89
/
€ 21,19
Vorige Slotkoers
€ 21,95
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -6,1 | 0,2 |
| P/B | 3,3 | 3,0 |
| ROE % | -58,9 | 3,6 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 9,9 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 44,00
+93.4%
Low: € 43,00
High: € 45,00
Forward WPA
-€ 3,76
Omzet Sch.
125.000,0
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 3,55
€ 1,66 – € 5,62
|
433,92M | 5 |
| FY2029 |
€ 0,84
€ 0,39 – € 1,34
|
266,77M | 2 |
| FY2028 |
-€ 1,47
-€ 3,61 – € 1,91
|
130,96M | 7 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-05 | -€ 0,85 | -€ 0,78 | +7,8% |
| 2025-11-10 | -€ 0,78 | -€ 0,83 | -6,4% |
| 2025-08-11 | -€ 0,70 | -€ 0,90 | -28,6% |
| 2025-05-12 | -€ 0,66 | -€ 1,90 | -187,9% |
| 2025-03-03 | -€ 0,78 | -€ 0,60 | +23,1% |
| 2024-11-14 | -€ 0,82 | -€ 0,61 | +25,6% |
| 2024-08-14 | -€ 0,65 | -€ 0,65 | 0,0% |
| 2024-05-08 | -€ 0,84 | -€ 0,70 | +16,7% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Debt/Equity of 0,00 — conservative balance sheet
Negative free cash flow of -160,59M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-58,88%
ROIC-43,34%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,00
Current Ratio12,83
Interest Coverage0,00
Waardering
P/E Ratio
-6,05
Forward P/EN/A
P/B Ratio3,27
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -166,31M |
| ROE | -58,88% | ROA | -49,92% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -160,59M |
| ROIC | -43,34% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 12,83 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -6,05 | Forward P/E | N/A |
| P/B Ratio | 3,27 | P/S Ratio | N/A |
| PEG Ratio | -0,07 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 8044,70 | Fwd Earnings Yield | N/A |
| FCF Yield | -15,97% | ||
| Market Cap | 1,01B | Enterprise Value | 960,06M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -166,31M | -80,49M | -69,33M | -36,91M | -51,61M |
| EPS (Diluted) | -4,32 | -2,56 | -2,17 | -1,10 | -40,44 |
| Gross Profit | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -177,53M | -94,31M | -74,59M | -36,91M | -8,70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 333,17M | 274,94M | 163,10M | 182,83M | 43,04M |
| Total Liabilities | 25,95M | 17,29M | 11,80M | 8,37M | 1,82M |
| Shareholders' Equity | 307,22M | 257,65M | 151,30M | 174,46M | 41,22M |
| Total Debt | 14.000,0 | 176.000,0 | 317.000,0 | 139.000,0 | 0,0 |
| Cash & Equivalents | 45,54M | 74,29M | 150,39M | 163,37M | 37,28M |
| Current Assets | 332,90M | 226,98M | 159,97M | 182,62M | 42,95M |
| Current Liabilities | 25,95M | 17,27M | 11,62M | 8,36M | 1,82M |